It's good to see that Merck is starting a new phase II trial of Cavatak(V937)/Keytruda in advanced melanoma .... I was worried that they had shelved the product.https://clinicaltrials.gov/ct2/show/NCT04152863?term=cavatak&recrs=abc&draw=2&rank=1.
NRX Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign
EXR HotCopper users humming as Elixir Energy reports first gas flowed to surface at Daydream-2, QLD; shares jump 15%
CC9 Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings
